Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-820,620
Closed -$12.1M 7663
2025
Q3
$12.1M Sell
820,620
-429,334
-34% -$4.38M ﹤0.01% 3116
2025
Q2
$12.3M Buy
1,249,954
+468,002
+60% +$3.88M ﹤0.01% 3034
2025
Q1
$5.68M Buy
781,952
+423,378
+118% +$3.7M ﹤0.01% 3680
2024
Q4
$2.8M Buy
358,574
+32,867
+10% +$271K ﹤0.01% 4149
2024
Q3
$2.41M Sell
325,707
-662
-0.2% -$5.57K ﹤0.01% 4421
2024
Q2
$2.61M Sell
326,369
-82,270
-20% -$735K ﹤0.01% 4213
2024
Q1
$4.76M Buy
408,639
+136,740
+50% +$1.51M ﹤0.01% 3657
2023
Q4
$3.04M Sell
271,899
-163,502
-38% -$1.5M ﹤0.01% 3992
2023
Q3
$6.72M Sell
435,401
-97,373
-18% -$1.63M ﹤0.01% 3127
2023
Q2
$10.1M Sell
532,774
-11,755
-2% -$206K ﹤0.01% 2697
2023
Q1
$8.29M Buy
544,529
+31,465
+6% +$410K ﹤0.01% 3015
2022
Q4
$6.53M Sell
513,064
-60,900
-11% -$548K ﹤0.01% 3134
2022
Q3
$3.32M Buy
573,964
+133,650
+30% +$587K ﹤0.01% 3785
2022
Q2
$1.42M Buy
440,314
+21,665
+5% +$65.4K ﹤0.01% 4601
2022
Q1
$1.58M Buy
418,649
+312,587
+295% +$2.01M ﹤0.01% 4819
2021
Q4
$1.39M Buy
106,062
+90,417
+578% +$1.43M ﹤0.01% 4940
2021
Q3
$306K Sell
15,645
-15,872
-50% -$290K ﹤0.01% 5997
2021
Q2
$590K Sell
31,517
-1,596
-5% -$35.6K ﹤0.01% 5292
2021
Q1
$783K Buy
33,113
+8,321
+34% +$192K ﹤0.01% 5028
2020
Q4
$604K Sell
24,792
-360,717
-94% -$9.22M ﹤0.01% 4877
2020
Q3
$9.89M Buy
385,509
+369,086
+2,247% +$11.7M ﹤0.01% 2304
2020
Q2
$327K Buy
16,423
+5,940
+57% +$144K ﹤0.01% 4930
2020
Q1
$265K Buy
10,483
+9,856
+1,572% +$288K ﹤0.01% 4919
2019
Q4
$17K Buy
+627
New +$17.4K ﹤0.01% 6533

Other funds holding ETNB

Bank of America's ETNB Position: Q4 2025 in Review

Bank of America sold out of 89bio (ETNB) in Q4 2025, closing a stake of 820,620 shares — an estimated $12.1M sold.

Bank of America first reported a position in ETNB in Q4 2019 and held it in 24 quarters. The position peaked at $12.3M in Q2 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Bank of America reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Bank of America sold 820,620 89bio shares in Q4 2025, an estimated $12.1M.
  • Bank of America first reported a position in 89bio in Q4 2019 and held it in 24 quarters.
  • Bank of America's 89bio position peaked at $12.3M in Q2 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Bank of America's 13F filing for Q4 2025, filed 17 Feb 2026.